The structure of a binary complex of dihy- 
Romann-type dinuceotide fold for NADH binding. Insertion of an extra threonine residue in the human enzyme is sciated with severe symptoms of a variant form ofphenylketonuria and maps to a tightly linked sequence of secondary-structural elements near the dimer interface. Dimerization Is mediated by a four-helix bundle motif (two helices from each protomer) having an unusual right-handed twist. DHPR is structurally and mechanistically distinct from dihydrofolate reductase, appearing to more closely resemble certain nicotiamide dinucleotide-requiring flavin-dependent enzymes, such as glutathione reductase.
Dihydropteridine reductase [DHPR; NAD(P)H:6,7-dihydropteridine oxidoreductase, EC 1.6.99.7] and the three aromatic amino acid hydroxylases of phenylalanine, tyrosine, and tryptophan play vital roles in the synthesis of the catecholamines, dopamine, epinephrine, and serotonin, and indirectly also influence generation of the melanin pigments. Tetrahydrobiopterin (BH4) is an essential cofactor in these metabolic pathways and facilitates the monooxygenase activity, which ultimately leads to the hydroxylation of the aromatic amino acid substrates (Fig. la) . In these reactions phenylalanine, tyrosine, and tryptophan are converted to tyrosine, dihydroxyphenylalanine, and 5-hydroxytryptophan, respectively, and the cofactor undergoes oxidation to a quinonoid dihydro form of biopterin (q-BH2). q-BH2 then becomes the substrate for DHPR and in an NADH-mediated reaction is recycled to BH4.
Defective function of the hydroxylation process has long been recognized clinically in the autosomal-recessive disease hyperphenylalaninemia or phenylketonuria (1) . Originally this disease was considered to correlate only with a defective phenylalanine hydroxylase, and although this is still primarily its predominant cause, a small percentage of cases have been identified as arising from defects either in DHPR function (2, 3) or in the biosynthetic route to BH4 (4). DHPR has always been identified with dihydrofolate reductase (DHFR) (Fig.  lb) , the enzymatic target for the chemotherapeutic agent methotrexate, insofar as each requires a reduced dinucleotide cofactor and a dihydropteridine substrate for activity. This report clearly eliminates the commonality ofthe two enzymes and, moreover, suggests a mechanistic comparison to certain flavin-requiring enzymes, an observation that reemphasizes the similarity of pterin and flavin chemistry proposed earlier by Hemmerich (5) , Viscontini (6) , and Wessiak and Bruice (7) . It should be noted that the protein structure described in this report is that of the rat liver enzyme; however, the (9) and, therefore, it is anticipated that any structural prediction made from the rat enzyme will apply to material from the human source as well.
MATERIALS AND METHODS
The crystals of the binary complex DHPR with NADH were grown under the same conditions that produced the monoclinic crystal form (10 (15) refinement were done with the standard restraints that also converged at 15.4%; however, rms deviation in bond lengths were reduced to 0.010 A. At the conclusion of refinement rms deviations for bond distances and angles were 0.010 A and 2.30, respectively.** Further details of the crystallographic analysis will be published elsewhere.
RESULTS AND DISCUSSION
DHPR is an a/P protein with a central twisted A-sheet flanked on each side by a layer of a-helices (Fig. 2) . The p-sheet has seven parallel strands and a single antiparallel strand at one edge leading to the carboxyl terminus of the protein. Connections between individual p-strands involve a-helices, except that PB and A3 are joined by a short stretch of polypeptide in random-coil conformation. Fig. 3 shows that the topology of the backbone folding of DHPR is quite distinct from that for DHFR (16 Although NADH can assume a folded conformation in solution, it usually binds to enzymes in an extended conformation with the nucleotide bases 10-15 A apart and the ring planes roughly perpendicular to one another. In DHPR, the center of the bound nicotinamide ring is 11 A from the center of the adenine pyrimidine ring. The adenine ring is in an anti conformation (X = 1550), as observed in the other structures, whereas as noted above, the nicotinamide glycosidic bond has a syn conformation (X = 67°). The DHPR-catalyzed transfer of the pro-S hydrogen of NADH to N5 of q-BH2 (21, 22) classifies the reductase as a B-stereospecific dehydrogenase (23) and conforms to the general rule that enzymes transferring the pro-S hydrogen bind nicotinamide in a syn conformation relative to the attached ribose ring (23) (24) (25) . Both ribose rings are puckered C2' endo. Rotation about the exocyclic C4'-C5' bond (y) plays a crucial role in positioning the 5'-phosphate group relative to the sugar and base. The +sc conformation observed for this dihedral in the NMN portion of NADH orients 05' over the ribose ring, resulting in a more folded structure for this half of the dinucleotide compared with the adenine mononucleotide portion, in which the corresponding torsion angle is in the -sc range. The combination of syn and +sc rotations forx and ypositions the carboxamide NH2 3.1 A from one of the 5'-phosphate oxygen atoms, resulting in a favorable intramolecular hydrogenbonding type of interaction, which probably stabilizes this particular overall conformation of the NMN mononucleotide.
DHPR exists in solution as a dimer. In the crystal form reported here the two individual subunits are related by a crystallographic 2-fold axis and, therefore, are necessarily identical. Helices aE and aF from one subunit come together with corresponding helices from the other subunit to form a four-helix cluster at the protomer interface (Fig. 4) . The four-helix bundle is a common structural motif in proteins.
Over a dozen such bundles have been identified, and recent interest has focused both on the topological connectivities between helices (26) and on the energetics of bundle assembly (27) . All four-helix clusters described to date are tilted so as to impart an overall left-handed twist. Except for the helical domain in lipovitellin-phosvitin (28) , the four adjacent helix pairs in known clusters are antiparallel. Helices aE and aF in DHPR are parallel to one another, providing but the second example of a four-helix bundle having two adjacent parallel and two adjacent antiparallel helices. In contrast to all other known four-helical domains, the helix cluster in DHPR has a right-handed twist with an orientation angle between neighboring antiparallel helix axes of around + 155°c ompared with a consensus value of about -163°for this angle in clusters with left-handed twists. Recently, Howells et al. (29) have reported severe symptoms of phenylketonuria associated with a deficient DHPR enzyme in which a single additional threonine residue is inserted after position 122 of the wild-type human amino acid sequence. In the rat liver enzyme, this would correspond to an insertion after residue 118 near the carboxyl terminus of aE (Fig. 4) on the backside of the molecule 25 A from the active site. The last residue of aE is Leu-122 followed immediately by a type II 3 turn (residues 123-126), in which residue 126 is also the first amino acid of PE. We anticipate that protein folding in this region of the human mutant DHPR will be significantly altered because the insertion can be accommodated only by disrupting backbone hydrogen bonding within the tightly linked sequence of secondary structural elements aE-type II , turn-,PE. The insertion may simply reduce subunit stability or increase sensitivity to proteases. The ability of subunits to form functional dimers could also E 124 be affected because alterations of protein conformation in this region would be expected to directly affect folding of the adjacent contacting loop (residues 160-170) that forms part of the dimer interface.
Near the carboxyl-terminal edge of the dinucleotide fold bounded on one side by the si-face of nicotinamide, there is a prominent cleft that must be the binding site for q-BH2. Protein residues contributing to the formation of this groove come from three extended loops that connect individual ,(strands within the central sheet-namely, the polypeptide chain linking /D to PE, PE to 8F, and PF to PG. In contrast to DHFR, where the pteridine ring of the substrate fits into a deep pocket, the substrate binding site in DHPR is a surface channel having a U-shaped cross section exposed to solvent at both ends.
To try to understand how substrate binds to DHPR, we used a molecular graphics terminal and attempted to dock the endo-isomer of q-BH2 within the cleft subject to the constraint that the N5 of the substrate should reside =3. 4 A from C4 of bound nicotinamide. Because of the narrow width of this groove, bounded on the bottom by the nicotinamide base and on the top by the indole side chain of Trp-86, the substrate must slip between these two heterocycles and bind with its pteridine ring nearly parallel to the nicotinamide plane, such that N5 is positioned directly above C4 of the cofactor. The best geometrical fit to the DHPR active site occurs when the re-face ofthe pteridine ring rotates above the nicotinamide in a stacked configuration, allowing the dihydroxypropyl side chain of the substrate to point away from the nicotinamide ring. Unless the loop connecting PD to f3E changes conformation upon binding q-BH2, the alternate docking mode, in which the si-face of the substrate points toward nicotinamide, appears to be disfavored because of steric crowding between the isopropyl side chain and the cofactor. Fig. 5 shows that the model predicts that N3 and the 2-NH2 group of q-BH2 are exposed to bulk solvent and are not involved in direct hydrogen bonding with DHPR. This interpretation is consistent with kinetic data showing that transient quinonoid species derived from various 2-substituted dihydropteridines, including 2-methyl, 2-methylthio, and 2-desamino analogs are good enzyme substrates (30, 31) . The model also suggests considerable tolerance for substitution at the 6 position because the edge of the pyrazine ring is also predicted to bind at the protein surface. This result probably explains why methotrexate is a good inhibitor of this enzyme (32) and why quinonoid dihydropterins derived from com- pounds having various 6-alkoxymethyl substituents including long (1-octyl) and branched (tert-butyl) side-chain analogs are excellent substrates (33) . In DHFR, a conserved carboxyl group protonates the dihydropteridine substrate before hydride transfer from NADPH. There are no amino acid side chains in the vicinity ofthe DHPR active site that could serve a similar function, suggesting that proton delivery to q-dihydropteridines is mediated directly by solvent.
Finally we call attention to the interesting structural similarity between the endo-q-isomer of q-BH2 and the isoalloxazine ring system ofoxidized flavins. Both molecules contain highly conjugated ring systems with identical dispositions of the four ring nitrogens. Moreover, flavin-dependent reductases using nicotinamide dinucleotides as a source of electrons also transfer hydride to N5. In our modeling of how q-BH2 may bind to DHPR in the presence of NADH we have been led to propose a geometrical relationship between substrate and cofactor very similar to that reported for the oxidized flavin ring of FAD and NADH bound to glutathione reductase (34) . A similar model was recently suggested for NADPH and FAD binding at the active site of ferrodoxin-NADP+ reductase (35) and mercuric ion reductase (36) .
